A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children’s…
(PRWeb November 02, 2022)
Read the full story at https://www.prweb.com/releases/pediatric_multicenter_study_shows_targeted_therapy_for_high_risk_hodgkin_lymphoma_reduces_relapse/prweb18997900.htm